3-Methyl-1H-pyrazole-4-boronic acid pinacol ester (also named as 3-Methyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrazole) is typically used in the preparation of PF-07059013, a noncovalent modulator of hemoglobin for treatment of sickle cell disease.
Integration of Enhanced Sampling Methods with Saturation Transfer Difference Experiments to Identify Protein Druggable Pockets.
PF-07059013: A Noncovalent Modulator of Hemoglobin for Treatment of Sickle Cell Disease. 
 J.Magalhaes, et al, J. Chem. Int. Model, 2018, 58(3), pp 710-723.
 A.Gopalsamy, et al, J. Med. Chem., 2021, 64(1), pp 326-342.
NONH for all modes of transport
1. Product Specification
2. Safety Data Sheet
Please inquire for pricing and availability of this product by writing email email@example.com.